Ipamorelin

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts on the GHS-R1a receptor in the pituitary gland. Research has looked at its role in growth hormone signaling and its receptor selectivity.

Overview

Ipamorelin is a synthetic pentapeptide that has been widely studied in laboratory settings for its selective interaction with growth hormone secretagogue (ghrelin) receptors and associated endocrine signalling pathways. It is supplied exclusively for controlled laboratory and research use and is intended only for qualified scientific investigation.

As part of Retro Wellness’ research compound range, Ipamorelin is presented with a focus on consistency, quality, and responsible sourcing. Each product is intended strictly for qualified research settings and should only be handled by individuals or organisations with the appropriate facilities, knowledge, and procedures.

Research involving Ipamorelin has explored its interaction with biological pathways associated with growth hormone secretion, ghrelin receptor activation, pituitary signalling, insulin-like growth factor-1 (IGF-1) regulation, and endocrine communication. It has also been investigated in broader studies examining hormonal signalling, metabolic regulation, and cellular communication across a range of experimental models. Ongoing research continues to expand understanding of its biological activity and potential relevance within endocrine, metabolic, and molecular research.

This product is not a medicine, supplement, cosmetic, or food product. It is not intended for human or veterinary use, diagnosis, treatment, prevention, or consumption.

What Research Has Explored

  • Acts on the GHS-R1a receptor
  • Research has looked at GH signaling pathways
  • Studied in the context of receptor selectivity research
  • Often investigated alongside CJC-1295 in research models

How It Works

Ipamorelin binds to GHS-R1a receptors in the pituitary gland and activates the phospholipase C/IP3/calcium signaling pathway. Research has characterized it as having a relatively selective receptor interaction profile compared to some other GHRPs. Ipamorelin has been studied alongside GHRH analogs like CJC-1295, which act through a different receptor pathway. Research has looked at how the two compounds interact with their respective receptors in research models.

Research Sources

Frequently Asked Questions

A synthetic pentapeptide studied as a selective growth hormone secretagogue.
Research has examined its interaction with the GHS-R1a receptor.
The two compounds act through different receptor pathways and have been investigated together in research models
No. This information is provided only for educational and research reference.
Product Name
Ipamorelin
Formulation
Lyophilized Powder
Strength
5 mg, 10 mg
Purity
>99% (HPLC)
Molecular Formula
n/a
Sequence
n/a
Cas Number
n/a

Related Products

For Qualified Laboratory Research Use Only

All products available on this site are supplied strictly for laboratory research use only. They are not intended for human or veterinary use, consumption, treatment, diagnosis or therapeutic application. Customers are responsible for ensuring products are handled, stored and used appropriately within a suitable research setting.